Our results also suggest that protective neuropeptides and trophic factors, such as PACAP, VIP or BDNF, may be considered as viable therapeutic targets to ameliorate the CNS damage caused by this debilitating form of SLE. This evidence concerns the gene ADCYAP1 and systemic lupus erythematosus.